RxDoctor Payments Data

Haleigh Marlowe

Physician Assistant · Vancouver, WANPI 1760147938

Payments from drug & device makers

$2,116in general payments, 2019–2025

Across 100 payments — averaging $21.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$267
  • AbbVie$251
  • Incyte Corporation$212
  • UCB, Inc.$170
  • Lilly USA, LLC$169
  • Sanofi$148
  • plus $900 from 26 others

What the payments were for

  • Food & beverage$2,116100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,116 in reported general payments places this provider in the 90th percentile of 2,741 physician assistant providers in Washington.

See all physician assistant providers in Washington

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide13$26,540
Atorvastatin Calcium74$905
Albuterol Sulfate HfaAlbuterol Sulfate11$786
Omeprazole27$630
Gabapentin30$563
Metformin Hcl46$448
Metoprolol Succinate31$368
Ketoconazole15$272
Estradiol13$268
Lisinopril25$206
Losartan Potassium20$201
Levothyroxine Sodium29$181
Amlodipine Besylate42$162
Triamcinolone Acetonide17$156
Simvastatin13$152

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$267$26,54013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,741 physician assistant providers in Washington.

Other physician assistant in Vancouver

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →